Schizophrenia is a complex multifactorial disorder characterized by positive and negative symptoms, the decline in cognitive performance, and neurophysiological deficits including impaired sensory gating. Creative Biolabs conducts contract studies in a most widely validated animal model of the positive, negative and cognitive symptoms of schizophrenia. This model is induced by administration of an open channel N-methyl-D-aspartate (NMDA) receptor blocker, phencyclidine (PCP). Learn more: pcp model
No Events